Mutation:BRCA1: Difference between revisions
Sequence
⎈ mutations with manual annotation;
pathogenic;
benign;
not yet reviewed;
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='' scene=''> | <StructureSection load='' size='340' side='right' caption='' scene=''> | ||
<div id='openPageText'> | |||
'''Some interesting mutation examples''': | '''Some interesting mutation examples''': | ||
Line 12: | Line 13: | ||
The most common cause of monogenic disease is a single base DNA variant resulting in an amino acid substitution. A set of structural effects, such as reduction in hydrophobic area, overpacking, backbone strain, and loss of electrostatic interactions, is used to represent the impact of single residue mutations on protein stability. The distinction between disease and non-disease variants, strongly supports the hypothesis that loss of protein stability is a major factor contributing to monogenic disease.<ref>pmid 16169011</ref> | The most common cause of monogenic disease is a single base DNA variant resulting in an amino acid substitution. A set of structural effects, such as reduction in hydrophobic area, overpacking, backbone strain, and loss of electrostatic interactions, is used to represent the impact of single residue mutations on protein stability. The distinction between disease and non-disease variants, strongly supports the hypothesis that loss of protein stability is a major factor contributing to monogenic disease.<ref>pmid 16169011</ref> | ||
</div> | |||
< | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == |